// company-profile

Sarepta Therapeutics, Inc.

SRPT
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings125Insiders16
// api This Sarepta Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 8 insiders purchased shares. Buying was led by Connelly Deirdre P.

// 90-day insight

Over the last 90 days, Sarepta Therapeutics, Inc. insiders bought $0 across 8 transactions with no open-market sales.

  • Most active insider: Connelly Deirdre P with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Sarepta Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$2.15B
QoQ change
+18.4%
Reporting period
2026-03-31
#1
BlackRock, Inc.
CIK 2012383
$214.5M
9.9M shares
#2
STATE STREET CORP
CIK 93751
$143.9M
6.6M shares
#3
AQR CAPITAL MANAGEMENT LLC
CIK 1167557
$136.7M
6.3M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 4, 2026Connelly Deirdre PSRPT
Award
16,875
Jun 4, 2026Wigzell Hans Lennart RudolfSRPT
Award
16,875
Jun 4, 2026Nicaise ClaudeSRPT
Award
16,875
Jun 4, 2026BEHRENS M KATHLEENSRPT
Award
16,875
Jun 4, 2026Mayo StephenSRPT
Award
16,875

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.